Toggle Dropdown
Groups
Announcements
Projects
Ideas
Welcome guest
Log in
Let's Practice
My Requests
All Requests
Drill Partners
Digital games
Projects
Goals
Loading
Loading...
https://www.cnbc.com/2023/10/29/here-are-5-anti-obesity-drug-stocks-besides-novo-nordisk-and-eli-lilly-to-watch-into-year-end.html
0
0
Here are 5 anti-obesity drug stocks besides Novo Nordisk and Eli Lilly to watch into year-end - CNBC
10/29/23 at 3:52am
Organization
CNBC
Author
Christina Cheddar Berk
44 words
0
Comments
Companies — both big and small — are hoping to grab a piece of the lucrative anti-obesity drug market. Piper Sandler counts 78 agents in development.
Business & Industrial
Health
CNBC
Novo Nordisk
Eli Lilly
anti-obesity drug market
Piper Sandler
You are the first to view
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...